Zhejiang Hisun Pharmaceutical Co., Ltd.

Overview

Zhejiang Hisun Pharmaceutical Co., Ltd. is a leading pharmaceutical company in China dedicated to the research, development, manufacturing, and distribution of a wide array of therapeutic drugs. With a strong focus on innovation and quality, Hisun aims to improve health by providing effective and accessible medications worldwide.

Core services & business areas

Therapeutic areas

Active pharmaceutical ingredients supplied

Substances Zhejiang Hisun Pharmaceutical Co., Ltd. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Zhejiang Hisun Pharmaceutical Co., Ltd. holds 24 active (89 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• APALUTAMIDEActive2025-12-30
• RESMETIROMActive2025-12-26
• FINERENONEActive2025-09-25
• LETERMOVIRActive2025-07-30
• TICAGRELORActive2014-12-25
• LINEZOLIDActive2014-09-05
• MICAFUNGIN SODIUM USPActive2013-09-25
• DOXORUBICIN HYDROCHLORIDE USP (FERMENTATION)Active2013-09-09
• DONEPEZIL HYDROCHLORIDE USPActive2012-12-27
• BLEOMYCIN SULFATE USP (PROCESS II)Active2012-09-21
• TIGECYCLINE USPActive2012-09-04
• MINOCYCLINE HYDROCHLORIDE USPActive2012-07-20
• MITOMYCIN USP (ALTERNATIVE PROCESS)Active2011-12-30
• IVERMECTIN USPActive2008-05-08
• DACTINOMYCIN USPActive2007-06-20

Showing 15 of 89 Drug Master Files.

FDA compliance signals